Crossmark

Risk factor analysis and predictive model development for secondary failure of platelet recovery following allogeneic hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1186/s12885-025-14653-4

Published Online: 2025-07-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peng, Xiru

Cheng, Juan
Funding

Funding for this research was provided by:

Analysis of the Efficacy and Safety of Azacitidine in Maintenance Therapy for Acute Myeloid Leukemia ((23)0379, (23)0379)
License Information

Text and Data Mining valid from 2025-07-29

Version of Record valid from 2025-07-29
More Information

Article History

Received: 31 March 2025

Accepted: 8 July 2025

First Online: 29 July 2025

Declarations

:

: The studies involving human participants were reviewed and approved by the Center for Ethics in the First Hospital of Lanzhou University. Written informed consent was obtained from patient for the publication of any potentially identifiable images or data included in this article.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below